NUCLEAR MEDICINE COMMUNICATIONS, cilt.36, sa.2, ss.109-113, 2015 (SCI-Expanded, Scopus)
Aim We aimed to assess the recurrence rates of papillary thyroid microcarcinoma in patients with and without histopathological risk factors after radioiodine (RAI) ablation treatment.